Apex Trader Funding - News
Grown Rogue Completes Fiscal Year End Change, Reports Audited Financial Results for the Two Months Ending December 31, 2023
Grown Rogue has completed its transition from an October 31 financial year end to a calendar year end, and is reporting a two-month stub period for the two months ending December 31, 2023
Revenue of $3.6M and Operating Cash Flow (OCF), before changes in working capital (WC), of $0.7M
Subsequent to period-end, the Company augmented New Jersey presence with a retail investment, announced entry into Illinois via a craft growers license, and announced the exercise and conversion of warrants, options, and debentures
MEDFORD, Ore., April 30, 2024 /CNW/ - Grown Rogue International Inc. ("Grown Rogue" or the "Company") (CSE:GRIN) (OTC:GRUSF), a craft cannabis company born from the amazing terroir of Oregon's Rogue Valley, is pleased to report its audited financial results for the two months ending December 31, 2023. The Company is reporting this two-month period as part of its earlier announced transition to a financial year end of December 31, so the Company's financial quarters align with peers on calendar quarters going forward and the Company's annual harvest cycle. All financial information is provided in U.S. dollars unless otherwise indicated.
Management Commentary
"We are excited to complete the transition of our fiscal year to now align with the calendar year. It was great to see that during November and December, typically the two slowest months for the Company, we saw 30% year-over-year revenue growth in our core markets of Oregon and Michigan," said Obie Strickler, CEO of Grown Rogue.
"We are also pleased with the construction and business planning progress in New Jersey and are excited to soon be bringing our high-quality, craft cannabis to the great people of New Jersey. We set aggressive timelines for the cultivation facility and would like to thank our team for their effort and commitment to achieving these timelines," continued Mr. Strickler.
"The recent warrant exercises, which resulted in the Company adding an additional US$4.7M in cash, have positioned us well to finance our current growth initiatives with cash on the balance sheet while leaving us with enough liquidity to move quickly if an attractive opportunity presents itself.
I want to personally thank the entire Grown Rogue team, our shareholders, and our customers for the continued support to help Grown Rogue achieve our goal of becoming the first nationally recognized craft cannabis company in the U.S."
Financial Statements and aEBITDA reconciliation
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
December 31, 2023
October 31, 2023
$
$
ASSETS
Current assets
Cash and cash equivalents
6,804,579
8,858,247
Accounts receivable (Note 18)
1,642,990
2,109,424
Biological assets (Note 3)
1,723,342
1,566,822
Inventory (Note 4)
5,021,290
4,494,257
Prepaid expenses and other assets
420,336
392,787
Total current assets
15,612,537
17,421,537
Property and equipment (Note 8)
8,820,897
8,753,266
Notes receivable (Notes 6.2.1 and 6.2.2)
2,449,122
1,430,526
Warrants asset (Note 13.2)
1,761,382
1,361,366
Intangible assets and goodwill (Note 9)
725,668
725,668
Deferred tax asset (Note 20)
246,294
470,358
TOTAL ASSETS
29,615,900
30,162,721
LIABILITIES
Current liabilities
Accounts payable and accrued liabilities
1,358,962
2,359,750
Current portion of lease liabilities (Note 7)
925,976
824,271
Current portion of long-term debt (Note 10)
780,358
1,285,604
Business acquisition consideration payable (Note 5)
360,000
360,000
Derivative liability (Notes 11.1.1, 11.2 and 11.2.1)
7,471,519
7,808,500
Income tax payable
873,388
366,056
Total current liabilities
11,770,203
13,004,181
Lease liabilities (Note 7)
1,972,082
2,094,412
Long-term debt (Note 10)
82,346
102,913
Convertible debentures (Notes 11.1, 11.2 and 11.2.1)
2,459,924
2,412,762
TOTAL LIABILITIES
16,284,555
17,614,268
EQUITY
Share capital (Note 12)
24,593,422
24,593,422
Contributed surplus (Notes 13 and 14)
8,186,297
8,081,938
Accumulated other comprehensive loss
(108,069)
(114,175)
Accumulated deficit
(20,353,629)
(20,996,449)
Equity attributable to shareholders
12,318,021
11,564,736
Non-controlling interests (Note 23)
1,013,324
983,717
TOTAL EQUITY
13,331,345
12,548,453
TOTAL LIABILITIES AND EQUITY
29,615,900
30,162,721
CONSOLIDATED STATEMENTS OF INCOME & LOSS
Two months ending
Year ended
AND COMPREHENSIVE INCOME & LOSS
December 31, 2023
October 31, 2023
$
$
Revenue
Product sales (Note 2.5)
3,542,037
22,424,169
Service revenue (Note 2.5.1)
96,050